Investor Announcements - 2018

Shareholder approval was received for a distribution in specie of shares in Renalytix AI plc to the Company's shareholders.

EKF Diagnostics announces the resolution from the General Meeting held earlier today.

EKF Diagnostics announces a briefing for all investors to provide details of the successful fundraising and proposed AIM admission of Renalytix AI plc.

Today the Company announced a successful, conditional equity fundraising by its spin-out business, Renalytix AI plc.

EKF Diagnostics confirms equity fundraising.

EKF Diagnostics Holdings plc announces that a general meeting of the Company will be held on 19 October 2018.

EKF Diagnostics Holdings plc  announces that it will release its interim results for the six months ended 30 June 2018 on Wednesday 19 September 2018.

EKF to undertake further market soundings ahead of a prospective equity Fundraising by Renalytix AI and the admission of its shares to trading on AIM.

Standard form for notification of major holdings.